279 related articles for article (PubMed ID: 24105467)
1. Presenilin influences glycogen synthase kinase-3 β (GSK-3β) for kinesin-1 and dynein function during axonal transport.
Dolma K; Iacobucci GJ; Hong Zheng K; Shandilya J; Toska E; White JA; Spina E; Gunawardena S
Hum Mol Genet; 2014 Mar; 23(5):1121-33. PubMed ID: 24105467
[TBL] [Abstract][Full Text] [Related]
2. The presenilin loop region is essential for glycogen synthase kinase 3 β (GSK3β) mediated functions on motor proteins during axonal transport.
Banerjee R; Rudloff Z; Naylor C; Yu MC; Gunawardena S
Hum Mol Genet; 2018 Sep; 27(17):2986-3001. PubMed ID: 29790963
[TBL] [Abstract][Full Text] [Related]
3. Levels of kinesin light chain and dynein intermediate chain are reduced in the frontal cortex in Alzheimer's disease: implications for axoplasmic transport.
Morel M; Héraud C; Nicaise C; Suain V; Brion JP
Acta Neuropathol; 2012 Jan; 123(1):71-84. PubMed ID: 22094641
[TBL] [Abstract][Full Text] [Related]
4. Presenilin controls kinesin-1 and dynein function during APP-vesicle transport in vivo.
Gunawardena S; Yang G; Goldstein LS
Hum Mol Genet; 2013 Oct; 22(19):3828-43. PubMed ID: 23710041
[TBL] [Abstract][Full Text] [Related]
5. Endogenous GSK-3/shaggy regulates bidirectional axonal transport of the amyloid precursor protein.
Weaver C; Leidel C; Szpankowski L; Farley NM; Shubeita GT; Goldstein LS
Traffic; 2013 Mar; 14(3):295-308. PubMed ID: 23279138
[TBL] [Abstract][Full Text] [Related]
6. GSK-3β Phosphorylation of Cytoplasmic Dynein Reduces Ndel1 Binding to Intermediate Chains and Alters Dynein Motility.
Gao FJ; Hebbar S; Gao XA; Alexander M; Pandey JP; Walla MD; Cotham WE; King SJ; Smith DS
Traffic; 2015 Sep; 16(9):941-61. PubMed ID: 26010407
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport.
Pigino G; Morfini G; Pelsman A; Mattson MP; Brady ST; Busciglio J
J Neurosci; 2003 Jun; 23(11):4499-508. PubMed ID: 12805290
[TBL] [Abstract][Full Text] [Related]
8. Disruption of axonal transport perturbs bone morphogenetic protein (BMP)--signaling and contributes to synaptic abnormalities in two neurodegenerative diseases.
Kang MJ; Hansen TJ; Mickiewicz M; Kaczynski TJ; Fye S; Gunawardena S
PLoS One; 2014; 9(8):e104617. PubMed ID: 25127478
[TBL] [Abstract][Full Text] [Related]
9. GSK-3beta-regulated interaction of BICD with dynein is involved in microtubule anchorage at centrosome.
Fumoto K; Hoogenraad CC; Kikuchi A
EMBO J; 2006 Dec; 25(24):5670-82. PubMed ID: 17139249
[TBL] [Abstract][Full Text] [Related]
10. Ethanol stimulates the in vivo axonal movement of neuropeptide dense-core vesicles in Drosophila motor neurons.
Iacobucci GJ; Gunawardena S
J Neurochem; 2018 Feb; 144(4):466-482. PubMed ID: 28960313
[TBL] [Abstract][Full Text] [Related]
11. Insulin signaling regulates a functional interaction between adenomatous polyposis coli and cytoplasmic dynein.
Gao FJ; Shi L; Hines T; Hebbar S; Neufeld KL; Smith DS
Mol Biol Cell; 2017 Mar; 28(5):587-599. PubMed ID: 28057765
[TBL] [Abstract][Full Text] [Related]
12. Presenilin-1 is an unprimed glycogen synthase kinase-3beta substrate.
Twomey C; McCarthy JV
FEBS Lett; 2006 Jul; 580(17):4015-20. PubMed ID: 16814287
[TBL] [Abstract][Full Text] [Related]
13. Molecular motor function in axonal transport in vivo probed by genetic and computational analysis in Drosophila.
Reis GF; Yang G; Szpankowski L; Weaver C; Shah SB; Robinson JT; Hays TS; Danuser G; Goldstein LS
Mol Biol Cell; 2012 May; 23(9):1700-14. PubMed ID: 22398725
[TBL] [Abstract][Full Text] [Related]
14. A stop or go switch: glycogen synthase kinase 3β phosphorylation of the kinesin 1 motor domain at Ser314 halts motility without detaching from microtubules.
Banerjee R; Chakraborty P; Yu MC; Gunawardena S
Development; 2021 Dec; 148(24):. PubMed ID: 34940839
[TBL] [Abstract][Full Text] [Related]
15. Differential roles of kinesin and dynein in translocation of neurofilaments into axonal neurites.
Lee S; Sunil N; Tejada JM; Shea TB
J Cell Sci; 2011 Apr; 124(Pt 7):1022-31. PubMed ID: 21363889
[TBL] [Abstract][Full Text] [Related]
16. GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila.
Mudher A; Shepherd D; Newman TA; Mildren P; Jukes JP; Squire A; Mears A; Drummond JA; Berg S; MacKay D; Asuni AA; Bhat R; Lovestone S
Mol Psychiatry; 2004 May; 9(5):522-30. PubMed ID: 14993907
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of dynein but not kinesin induces aberrant focal accumulation of neurofilaments within axonal neurites.
Motil J; Dubey M; Chan WK; Shea TB
Brain Res; 2007 Aug; 1164():125-31. PubMed ID: 17640622
[TBL] [Abstract][Full Text] [Related]
18. A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons.
Morfini G; Szebenyi G; Brown H; Pant HC; Pigino G; DeBoer S; Beffert U; Brady ST
EMBO J; 2004 Jun; 23(11):2235-45. PubMed ID: 15152189
[TBL] [Abstract][Full Text] [Related]
19. Drosophila Miro is required for both anterograde and retrograde axonal mitochondrial transport.
Russo GJ; Louie K; Wellington A; Macleod GT; Hu F; Panchumarthi S; Zinsmaier KE
J Neurosci; 2009 Apr; 29(17):5443-55. PubMed ID: 19403812
[TBL] [Abstract][Full Text] [Related]
20. Nebula/DSCR1 upregulation delays neurodegeneration and protects against APP-induced axonal transport defects by restoring calcineurin and GSK-3β signaling.
Shaw JL; Chang KT
PLoS Genet; 2013; 9(9):e1003792. PubMed ID: 24086147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
